Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
In Search of Mouse Model for Exfoliation Syndrome
Author Affiliations & Notes
  • Samuel Insignares
    Ophthalmology and Visual Science, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Sharon Yang
    Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • John Kuchtey
    Ophthalmology and Visual Science, Vanderbilt University Medical Center, Nashville, Tennessee, United States
  • Rachel W Kuchtey
    Ophthalmology and Visual Science, Vanderbilt University Medical Center, Nashville, Tennessee, United States
    Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States
  • Footnotes
    Commercial Relationships   Samuel Insignares None; Sharon Yang None; John Kuchtey None; Rachel Kuchtey None
  • Footnotes
    Support  NEI R01EY020894; The Glaucoma Foundation; Departmental unrestricted award by Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 6137. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Samuel Insignares, Sharon Yang, John Kuchtey, Rachel W Kuchtey; In Search of Mouse Model for Exfoliation Syndrome. Invest. Ophthalmol. Vis. Sci. 2024;65(7):6137.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Exfoliation syndrome (XFS) is a systemic connective tissue disorder. Though the mechanism is unknown, Loxl1-/- mice recapitulate some mild ocular features of XFS, indicating lysyl oxidase like 1 (LOXL1 encoded by LOXL1) is involved in pathophysiology. We hypothesize elastic fiber defects caused by inadequate elastin crosslinking due to lack of LOXL1, combined with microfibril deficiency due to FBN1 mutation (encoding fibrillin-1, Fbn1C1041G/+), will display ocular and systemic phenotypes of XFS.

Methods : Loxl1-/- (gift from Tiansen Li) was backcrossed to C57BL/6J background, then crossed with Fbn1C1041G/+ to create double mutant (dbm; Fbn1C1041G/+; Loxl1-/-) mice. Ocular features such as intraocular pressure (IOP) measured by tonometry, visual acuity (VA) measured by optomotor reflex, and biometry measured by optical coherence tomography (OCT) were characterized in 4 genotypes (wt, Fbn1C1041G/+, Loxl1-/-, dbm) at 4 months old. Optic nerves (ON) were fixed, and cross-section area measured by ImageJ. Phenotyping was performed in cardiovascular and pulmonary systems. Two-tailed student’s t-test was used for statistical analysis.

Results : At 4 months old, there was no significant difference in IOP between the 4 genotypes. VA was significantly reduced only in dbm compared to wt. Majority of biometric parameters showed significant difference in all 3 mutant genotypes compared to wt, and dbm had exacerbated anomalies when compared to single mutants. Dbm ON areas were significantly larger when compared to age-matched wt (Figure 1). Cardiovascular phenotype revealed cardiomegaly and ascending aortic dilation in dbm (n=6, 0.13±0.03g, 1.1±0.1mm) compared to wt (n=5, 0.07±0.01g, 0.62±0.08mm, p=0.002 and p=0.0005, respectively). Histological examination showed fragmented elastin fibers of ascending aortic wall, multifocal leukocytoclastic aortitis, arteritis, and valvulopathy of both atrioventricular valves, and severe emphysema and bronchiectasis in the lungs of dbm mice.

Conclusions : Ocular and systemic findings in dbm mice support interaction between fibrillin-1 and LOXL1, two prominent components of exfoliation material. Reduced VA in dbm could be due to refractive errors caused by biometric changes, and/or reduced retinal ganglion cell function by enlarged ON as shown previously. The systemic findings of dbm mice also provide insight on the link of XFS with cardiovascular and pulmonary diseases in humans.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Ocular Phenotypes

Ocular Phenotypes

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×